Mammalian Enteral Ventilation - a new way to breathe

  • Thread starter Thread starter Tom.G
  • Start date Start date
  • Tags Tags
    Ventilation
Click For Summary
Recent research demonstrates that blood oxygenation can be achieved through the lower intestinal tract in both mice and pigs, potentially offering a new method for temporarily assisting human respiratory function. This enteral ventilation technique draws inspiration from loaches, which utilize intestinal air breathing. The study shows that intra-rectal delivery of a liquid oxygen compound, specifically conjugated perfluorocarbon, is both well-tolerated and effective in treating severe respiratory failure. This innovative approach may pave the way for new clinical applications in respiratory support.
Tom.G
Science Advisor
Gold Member
Messages
5,661
Reaction score
4,504
From: https://www.cell.com/med/fulltext/S2666-6340(21)00153-7?utm_source=EA

Blood oxygenation through the lower intestinal tract is demonstrated in both mice and pigs. It is hoped this wiil work for those Humans that need temporary assistance with respiratory function.

Inspired by organisms such as loaches that use intestinal air breathing, we show the effectiveness of an enteral ventilation approach in attaining systemic oxygenation in both rodent and porcine models. Intra-rectal delivery of a liquid form of O2 known as conjugated perfluorocarbon, a compound historically used in clinics for liquid ventilation through airway administration, is highly tolerable and efficacious in ameliorating severe respiratory failure.
 
  • Like
  • Informative
Likes BillTre and hmmm27
Biology news on Phys.org
I stumbled across this article, "Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir" https://pmc.ncbi.nlm.nih.gov/articles/PMC11985979/ I was curious about (3-hydroxy-2-phosphonylmethoxypropyl) I also found a related article in the context of anitviral polymerase inhibitors: Progression of Antiviral Agents Targeting Viral Polymerases...